Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06321029 · ClinicalTrials.gov registry record · NA

Electronic Diabetes Tune-Up Group (eDTU) for African Americans

A NA study of Diabetes Mellitus, Type 2 and Diabetes Complications, sponsored by Indiana University.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06321029: Active NA study of Diabetes Mellitus, Type 2 and Diabetes Complications, sponsored by Indiana University.

NCT06321029 is a NA study of Diabetes Mellitus, Type 2 and Diabetes Complications that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 60 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06321029, a NA study of Diabetes Mellitus, Type 2 and Diabetes Complications, is active but no longer recruiting, sponsored by Indiana University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The primary aims of this study are: 1. To test the acceptability and feasibility of the electronic DTU intervention (eDTU) that has been adapted for cultural relevance and online delivery compared to waitlist control and the in-person DTU (iDTU). The hypothesis is that the adapted intervention will be culturally acceptable (by participant satisfaction scores) and well-subscribed (intervention attendance rates). 2. To test differences in diabetes distress and A1c change scores between intervention (changes in T2 to T4) and waitlist control (change in T1 to T2) by intervention group (eDTU vs. waitlist control; iDTU vs. waitlist control). The hypothesis is that both the eDTU and iDTU groups will show significant improvements in diabetes distress and A1c compared to waitlist control. In order to conserve sample size and budget, participants in each intervention group will serve as their own waitlist control. Secondary Objective. The secondary aim of the study is to evaluate changes in depressive symptoms, diabetes self-efficacy, and general and diabetes-specific quality of life in intervention (T2-T3 \& T4) compared to waitlist control (T1-T2). An exploratory aim will be to compare changes in eDTU to the iDTU pre/post intervention (T2-T3 \& T4). The hypothesis is that both groups will show comparable improvements in diabetes distress and A1c.

Primary Outcome

Change in DDS-17 scores over time; scores range from 1 - 6 with higher scores indicating worse diabetes distress

Interventions

  • BEHAVIORAL Diabetes Tune-Up Group

Study Locations (1)

Indiana

  • Indiana University School of Medicine - Indianapolis

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-10-19
Est. Completion 2026-03-31
Phase NA
Indiana University

890 total trials

What the registry record for NCT06321029 still lists

NCT06321029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Tune-Up Group is the first listed.

NCT06321029 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT06321029 about?

NCT06321029 is a clinical study titled "Electronic Diabetes Tune-Up Group (eDTU) for African Americans". The primary aims of this study are: 1. To test the acceptability and feasibility of the electronic DTU intervention (eDTU) that has been adapted for cultural relevance and online delivery compared to waitlist control and the in-person DTU (iDTU). The hypothesis is that the adapted intervention will...

What is the current status of trial NCT06321029?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-10-19. Estimated completion is 2026-03-31.

What conditions does trial NCT06321029 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Diabetes Complications.

What interventions are being tested in trial NCT06321029?

The interventions under investigation include: Diabetes Tune-Up Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT06321029?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06321029 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06321029's enrollment target sits among peer trials

60 246th of 348 higher than 98 of 348 other Diabetes Mellitus, Type 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06321029, the US trial registry maintained by the National Library of Medicine. NCT06321029 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.